| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.NEULET.2007.04.001 |
| P698 | PubMed publication ID | 17442489 |
| P50 | author | Michael Berk | Q30504747 |
| Paulo Belmonte-de-Abreu | Q47306796 | ||
| Mauricio Kunz | Q56935942 | ||
| Ana C Andreazza | Q59668505 | ||
| Flávio Kapczinski | Q77015947 | ||
| Clarissa Severino Gama | Q77047141 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bipolar disorder | Q131755 |
| schizophrenia | Q41112 | ||
| P304 | page(s) | 45-48 | |
| P577 | publication date | 2007-04-04 | |
| P1433 | published in | Neuroscience Letters | Q7002625 |
| P1476 | title | Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder | |
| P478 | volume | 420 |
| Q26786354 | A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical Correlates |
| Q39394400 | A comparison of the neutrophil-lymphocyte, platelet-lymphocyte and monocyte-lymphocyte ratios in schizophrenia and bipolar disorder patients - a retrospective file review |
| Q28539784 | A longitudinal study of alterations of hippocampal volumes and serum BDNF levels in association to atypical antipsychotics in a sample of first-episode patients with schizophrenia |
| Q33777980 | A new avenue for lithium: intervention in traumatic brain injury |
| Q42957356 | Acute Low Back Pain: Differential Somatosensory Function and Gene Expression Compared With Healthy No-Pain Controls. |
| Q47717590 | Adjunctive memantine for schizophrenia: a meta-analysis of randomized, double-blind, placebo-controlled trials |
| Q48678119 | Altered BDNF is correlated to cognition impairment in schizophrenia patients with tardive dyskinesia. |
| Q47559874 | Association of serum brain derived neurotropic factor with duration of drug-naive period and positive-negative symptom scores in drug naive schizophrenia |
| Q36589545 | BDNF-TrkB signaling and neuroprotection in schizophrenia |
| Q38769563 | Brain-Derived Neurotrophic Factor Expression in Individuals With Schizophrenia and Healthy Aging: Testing the Accelerated Aging Hypothesis of Schizophrenia |
| Q37203365 | Brain-derived neurotrophic factor and neuroplasticity in bipolar disorder |
| Q34613454 | Brain-derived neurotrophic factor in human saliva: ELISA optimization and biological correlates |
| Q34132832 | Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis |
| Q48208291 | Can BDNF and IL-2 be indicators for the diagnosis in schizophrenic patients with depressive symptoms? |
| Q88013349 | Contribution of Endocannabinoid Gene Expression and Genotype on Low Back Pain Susceptibility and Chronicity |
| Q36567277 | DNA Methylation of BDNF Gene in Schizophrenia. |
| Q48447557 | Decreased levels of serum brain-derived neurotrophic factor in drug-naïve first-episode schizophrenia: relationship to clinical phenotypes |
| Q35284133 | Decreased serum levels of brain-derived neurotrophic factor in schizophrenic patients with deficit syndrome |
| Q43135416 | Different patterns of longitudinal changes in plasma levels of catecholamine metabolites and brain-derived neurotrophic factor after administration of atypical antipsychotics in first episode untreated schizophrenic patients |
| Q36404577 | Is serum brain-derived neurotrophic factor a biomarker for cognitive enhancement in schizophrenia? |
| Q45903198 | Ketamine alters behavior and decreases BDNF levels in the rat brain as a function of time after drug administration. |
| Q38760788 | Longitudinal assessment of brain-derived neurotrophic factor in Sardinian psychotic patients (LABSP): a protocol for a prospective observational study. |
| Q48694105 | Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia |
| Q26766487 | Molecular Pathways Bridging Frontotemporal Lobar Degeneration and Psychiatric Disorders |
| Q37489488 | Neurobiological trait abnormalities in bipolar disorder |
| Q36755750 | Neuroprotective and neurogenesis agent for treating bipolar II disorder: add-on memantine to mood stabilizer works. |
| Q35687024 | Neurotrophins role in depression neurobiology: a review of basic and clinical evidence |
| Q38125218 | Neurotrophins, inflammation and oxidative stress as illness activity biomarkers in bipolar disorder |
| Q42957019 | Nicotine dependence and serum BDNF levels in male patients with schizophrenia |
| Q35550864 | Peripheral BDNF: a candidate biomarker of healthy neural activity during learning is disrupted in schizophrenia |
| Q38550939 | Peripheral blood brain-derived neurotrophic factor in bipolar disorder: a comprehensive systematic review and meta-analysis |
| Q48507006 | Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications |
| Q34879109 | Pharmacotherapy for treatment-resistant schizophrenia. |
| Q37316080 | Plasma BDNF is reduced among middle-aged and elderly women with impaired insulin function: evidence of a compensatory mechanism |
| Q30977897 | Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections |
| Q37517959 | Review of lithium effects on brain and blood |
| Q46164184 | Serum levels of brain-derived neurotrophic factor and thiobarbituric acid reactive substances in chronically medicated schizophrenic patients: a positive correlation |
| Q48427629 | Serum levels of brain-derived neurotrophic factor correlate with motor impairment in Parkinson's disease |
| Q48363388 | The BDNF Val66Met polymorphism and plasma brain-derived neurotrophic factor levels in Han Chinese patients with bipolar disorder and schizophrenia |
| Q28066603 | The Efficacy of Non-Pharmacological Interventions on Brain-Derived Neurotrophic Factor in Schizophrenia: A Systematic Review and Meta-Analysis |
| Q52308849 | The complex association between the antioxidant defense system and clinical status in early psychosis. |
| Q43376611 | The search for new biomarkers for cognition in schizophrenia |
| Q38089247 | The search for peripheral disease markers in psychiatry by genomic and proteomic approaches |
| Q37615022 | Vascular endothelial growth factor and brain-derived neurotrophic factor in quetiapine treated first-episode psychosis |
| Q30959630 | What's New in Traumatic Brain Injury: Update on Tracking, Monitoring and Treatment |
| Q64902225 | Whole blood transcriptomic profiles can differentiate vulnerability to chronic low back pain. |
Search more.